Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Abaloparatide Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Entera Bio Reveals EB613's Positive Impact on Osteoporosis
    Entera Bio Reveals EB613's Positive Impact on Osteoporosis

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3146096/0/en/Entera-Bio-Presents-Positive-Effects-of-EB613-on-Both-Trabecular-and-Cortical-Bone-in-Postmenopausal-Women-with-Osteoporosis-at-ASBMR-2025.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    Radius Pharma Signs Agreement with Pharmanovia for Abaloparatide
    Radius Pharma Signs Agreement with Pharmanovia for Abaloparatide

    02 Jan 2025

    // ACCESSWIRE

    https://www.accesswire.com/962075/radius-pharmaceuticals-announces-licensing-agreement-with-pharmanovia-to-register-and-commercialize-abaloparatide-in-china-and-select-asia-pacific-territories

    ACCESSWIRE
    02 Jan 2025
    Share Share
    Radius Pharma Expands Abaloparatide Licensing Agreement
    Radius Pharma Expands Abaloparatide Licensing Agreement

    09 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/951473/radius-pharmaceuticals-expands-abaloparatide-licensing-agreement-with-theramex-granting-additional-commercialization-rights-including-mexico-canada-south-africa-israel-and-russia

    ACCESSWIRE
    09 Dec 2024
    Share Share
    US FDA grants approval for Radius’ Tymlos for osteoporosis in men
    US FDA grants approval for Radius’ Tymlos for osteoporosis in men

    22 Dec 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/fda-radius-tymlos-osteoporosis/

    PHARMACEUTICAL-TECHNOLOGY
    22 Dec 2022
    Share Share
    Teijin Pharma Receives Approval Japan for Abaloparatide Acetate for Osteoporosis
    Teijin Pharma Receives Approval Japan for Abaloparatide Acetate for Osteoporosis

    05 Sep 2022

    // PRESS RELEASE

    https://www.teijin.com/news/2022/09/05/20220905_01.pdf

    PRESS RELEASE
    05 Sep 2022
    Share Share
    Radius Health Update on Abaloparatide Transdermal System
    Radius Health Update on Abaloparatide Transdermal System

    01 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/01/2454734/31149/en/Radius-Health-Update-on-Abaloparatide-Transdermal-System.html

    GLOBENEWSWIRE
    01 Jun 2022
    Share Share